Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
Ishiguro, Department Of Clinical Genetics, Graduate School Of Medical Science, University Of Yamanashi, Department Of Neuropsychiatry, Kibret, Berhanu Geresu, Department Of Biology, College Of Science, Health
Cannabinoid type 2 receptor signaling. The involvement of CB2Rs in ALS has been demonstrated by different studies. Brain cannabinoid CB2 receptors modulate cocaine’s actions in mice. What we know and do not know about the cannabinoid receptor 2 (CB2). Al Mansouri S, Ojha S, Al Maamari E, Al Ameri M, Nurulain SM, Bahi A.
Tags:
- Cannabinoid receptor type 2
- Cannabinoid receptor
- Microglia
- Addiction
- Schizophrenia
- Psychosis
- Experimental autoimmune encephalomyelitis
- Neurodegenerative disease
- Neuroinflammation
- Amyotrophic lateral sclerosis
- Multiple sclerosis
- Autism spectrum
- Cannabinoid
- Eating disorder
- Neuron
- Mental disorder
- Inflammation
- Depression (mood)
- Traumatic brain injury
- Oxidopamine
- Receptor antagonist
- Huntingtons disease
- Major depressive disorder
- Substantia nigra
- Amyloid beta
- Brain
- Seizure
- Synapse
- Dizocilpine
- Dopamine
- MPTP
- Alcohol (drug)
- Gene expression
- Huntingtin
- Self-administration
- Methamphetamine
- Clinical medicine
- Medicine
- Diseases and disorders
- Biochemistry
- Medical specialties
- Health
- Neuroscience